Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-027501
Filing Date
2012-05-10
Accepted
2012-05-10 20:50:16
Documents
1
Period of Report
2012-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5148
  Complete submission text file 0001209191-12-027501.txt   6658
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
ADVENTRX PHARMACEUTICALS INC (Issuer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address HALOZYME THERAPEUTICS, INC. 11588 SORRENTO VALLEY ROAD, #17 SAN DIEGO CA 92121
Business Address
RAMSAY DAVID A (Reporting) CIK: 0001283292 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32157 | Film No.: 12831955